Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: BASi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: BASi

Service revenues up 14% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi

3Q Revenues: $6.0 million (+8%)

3Q Earnings: $215,000 (-63%)

YTD Revenues: $18.2 million (+10%)

YTD Loss: $666,000 (earnings were $521 million YTD13)

Comments: Service revenue in the quarter increased 14% to $4.8 million primarily due to higher toxicology revenue, offset slightly by lower bioanalytical analysis revenue. Product revenue decreased 12% to $1.3 million. Earnings in the quarter and YTD were affected by non-cash decreases in the fair value of warrant liability of $66,000 and $1.1 million, respectively.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics